CMS shares new coverage details for Alzheimer's drug Leqembi

CMS has released new information about the data that clinicians must provide to patient registries when prescribing Leqembi (lecanemab).

Related Keywords

, Centers For Medicare Medicaid Services , Drug Administration , Medicaid Services , Antibodies Directed Against Amyloid , Disease Registry ,